Exencial Wealth Advisors’s AstraZeneca AZN Stock Holding History

Exencial Wealth Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.98M	Buy	20,162 +1,755	+10%	+$338K	0.12%	163
2025 Q4	$3.38M	Buy	18,407 +819	+5%	+$144K	0.11%	172
2025 Q3	$2.7M	Buy	17,588 +1,231	+8%	+$186K	0.09%	189
2025 Q2	$2.29M	Buy	16,357 +830	+5%	+$116K	0.08%	202
2025 Q1	$2.28M	Buy	15,527 +3,443	+28%	+$498K	0.08%	200
2024 Q4	$1.58M	Buy	+12,084	New	+$1.69M	0.06%	240
2022 Q1	–	Sell	-2,803	Closed	-$327K	–	456
2021 Q4	$327K	Buy	2,803 +808	+41%	+$95.1K	0.02%	374
2021 Q3	$240K	Sell	1,995 -397	-17%	-$46.2K	0.01%	297
2021 Q2	$287K	Sell	2,392 -27	-1%	-$2.96K	0.02%	383
2021 Q1	$241K	Buy	+2,419	New	+$243K	0.01%	383
2020 Q4	–	Sell	-2,066	Closed	-$226K	–	375
2020 Q3	$226K	Buy	+2,066	New	+$230K	0.01%	333

Other funds holding AZN

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Asset Management London, Ec4n 8af $148B AUM

Exencial Wealth Advisors's AZN Position: Q1 2026 in Review

Exencial Wealth Advisors increased its AstraZeneca (AZN) stake by 9.5% in Q1 2026, buying an estimated $338K and bringing the position to 20,162 shares worth $3.98M. The position accounts for 0.12% of the portfolio, ranked #163.

Exencial Wealth Advisors first reported a position in AZN in Q3 2020 and has held it in 11 quarters since. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Exencial Wealth Advisors held 20,162 shares of AstraZeneca worth $3.98M as of Q1 2026.
Exencial Wealth Advisors bought 1,755 AstraZeneca shares in Q1 2026, an estimated $338K.
AstraZeneca made up 0.12% of Exencial Wealth Advisors's portfolio in Q1 2026, its #163 holding.
Exencial Wealth Advisors first reported a position in AstraZeneca in Q3 2020 and has held it in 11 quarters since.
1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.